Review
Nov 2026
Abstract 8247: National Trends and In-Hospital Outcomes of TAVR+PCI Versus SAVR+CABG in Aortic Stenosis: Impact of the Low-Risk TAVR Era
Background: Transcatheter Aortic Valve Replacement (TAVR) is a less invasive alternative to Surgical Aortic Valve Replacement (SAVR) for the treatment of aortic stenosis (AS). Following FDA approval for low-risk patients in 2019 and incorporation into the 2020 valvular heart disease guidelines, utilization of TAVR h...
C. Sohail, Zeshan Tariq Malik, Muzamil Hussain et al.
· Circulation · 0 citations